The ETF is heavily weighted toward technology-related growth stocks, and with inflation and interest rates rising, it hasn't been a good time for those companies. Besides, the reason for reduced net income is transitory as the company pays down its expenses related to acquisitions that will eventually be accretive to its bottom line. Teladoc benefits from its brand name Telemedicine had a moment during the COVID-19 pandemic, but unlike some other pandemic-related plays, long-term growth in telehealth is here to stay.